Skip to content
thestock.space

On 5 Nov 2026, Novateor Research Laboratories was priced at ₹40.00, or 235.3× trailing earnings, and the shares are 17% below their 52-week high. It earns ROCE of 1.6% and ROE of 0.9%, and sales and net profit grew 45% and 40% a year over 3 years, though net profit is above operating profit, which points to a one-off gain. The company has almost no debt. It is a small-cap company with a market cap of ₹24 Cr; the shares rose 54% over the past year.

As of 5 Nov 2026Prices are delayed about 15 minutes.How we calculate this

past year
Open
₹48.00
Day high
₹48.00
Day low
₹40.00
Prev. close
₹40.00
Volume
6K

Health check

2 good · 3 to check
  • ReturnsStrong

    +53.8% over the past year.

  • Price tagDistorted

    A one-off gain inflates profit, so P/E isn’t comparable right now.

  • GrowthStrong

    Sales +44.8%, profit +40.3% a year over 3 years.

  • ProfitabilityWeak

    ROCE 1.6%.

  • Balance sheetStretched

    Debt 0.08× equity, operating profit doesn’t cover interest.

  • Red flags4 to check

    Return on equity is low at 0.9%.

Computed from reported figures. Educational, not a recommendation.

Household & Personal Products

Small cap

₹24 Cr

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months: sales ₹4 Cr · profit ₹0 Cr
Market cap
₹24 Cr
Small cap
P/E
235.3
Price to book
2.10
Book value ₹19.01
Dividend yield
0.00%
ROE
0.9%
Return on equity
ROCE
1.6%
Return on capital employed
Debt to equity
0.08
Debt ₹0.92 Cr
EPS (TTM)
₹0.17
OPM (TTM)
−6.1%
Net margin 2.6%
Sales growth
−31.6%
Latest quarter vs a year ago
Profit growth
+176.4%
Latest quarter vs a year ago
Price to sales
6.33
EV/EBITDA −236.2

Strengths and risks

Strengths

  • Practically debt-free.
  • Quarterly profit up 176.4% on a year ago.

Risks to check

  • Return on equity is low at 0.9%.
  • Quarterly sales down 31.6% on a year ago.
  • Net profit is above operating profit, so a one-off gain is likely flattering earnings.
  • Interest coverage of only −1.3×.

Derived automatically from reported figures. Not a recommendation.

About Novateor Research Laboratories

Novateor Research Laboratories Limited engages in the development and sale of novel personal care products in India. It offers tongue cleaners, teeth whitening strips, toothpaste, toothbrushes and accessories, mouthwashes/rinses, denture products, dental accessories/ancillaries, and dental prosthesis cleaning solutions. The company sells its products to dentists and cosmetic parlors. It offers teeth whitening products under SmiloShine brand. The company…

Headquarters
Ahmedabad
Employees
17
Sector
Consumer Defensive
ISIN
INE08JY01013

Price range

52 weeks

₹20.08₹48.00

Today

₹40.00₹48.00
Avg volume (3M)
580
1-year return
plus 53.8%
From 52-week high
minus 16.7%

Peers

We couldn’t find listed peers for this company.

Quarterly results

This company doesn’t report these figures in a format we can read yet.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+44.8%
Profit CAGR 3Y
+40.3%
ROE
0.9%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1.31.22.83.8
–minus 4.2%+130.1%+37.8%
1.61.52.93.9
−0.3−0.3−0.1−0.1
−25.0%−24.2%−4.2%−2.7%
0.50.50.50.5
000.10.1
0.10.10.20.2
−0−0−0–
000.10.1
7.3%36.7%27.7%10.9%
000.10.1
–minus 20.1%+179.2%+23.7%
0.080.050.14–

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
4.84.84.86.1
33.95.75.5
0.81.10.91
0.20.61.21.7
910.512.614.3
2.22.93.43.3
0.40.4––
0000
0.20.10.30.5
6.178.910.5
910.512.614.3

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
−1−1−1−0.2
0.1−0.3−0.2−0.5
0.61.11.40.9
−0.3−0.10.20.2
−0.4−0.7−0.7−0
−1.3−1.7−1.7−0.2
−0–––

Shareholding pattern

This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.

Major shareholders

BSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you